JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B4953 Methylprednisolone Sodium Succinate

Target: Glucocorticoid Receptors

Summary: glucocorticoid

≥49.7 mg/mL
B5940 TP-0903

Target: AXL

Summary: AXL receptor tyrosine kinase inhibitor, anti-cancer agent

≥25.8 mg/mL
B6031 GMX1778 (CHS828)

Summary: NAMPT inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.3 mg/mL
L1021 DiscoveryProbe™ FDA-approved Drug Library
77 Citation

Summary: 2320 approved drugs and API from pharmacopoeia
B6075 Monastrol

Summary: Eg5 inhibitor
B1609 Aclidinium Bromide

Summary: LAMAs antagonist

≥28.23 mg/mL
B2174 GSK2334470

Summary: PDK1 inhibitor,highly specific and potent

≥46.3 mg/mL
B1263 CBB1007

Summary: LSD1 inhibitor,potent and selective

Soluble in DMSO
B1070 AHU-377(Sacubitril)

Target: neprilysin

Summary: Neprilysin inhibitor

≥41.1 mg/mL
B2171 Imatinib (STI571)
6 Citation

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Protein-tyrosine kinase inhibitor

≥24.68 mg/mL